Kyverna Therapeutics is a clinical-stage biopharmaceutical company dedicated to advancing the treatment options for patients suffering from autoimmune diseases. The company specializes in developing cutting-edge cell therapies that utilize advanced T cell engineering to target and eliminate autoreactive immune cells responsible for these conditions. Kyverna's mission is to transform the landscape of autoimmune disease treatment and improve patient outcomes through innovative therapeutic platforms. In fostering a collaborative and intellectually rigorous work environment, Kyverna embraces core values that include elevating one another and staying true to their purpose. The company seeks talented individuals passionate about making a meaningful impact in healthcare, inviting them to contribute to their vision of freeing patients from the burdens of autoimmune diseases.